Rebastinib (DCC-2036)
Product Specifications
CAS Number
1020172-07-9
SKU
C16967-50mg
Target
Bcr-Abl
Applications
Protein Tyrosine Kinase
Smiles
CC (C) (C) C1=NN (C (=C1) NC (=O) NC2=C (C=C (C=C2) OC3=CC (=NC=C3) C (=O) NC) F) C4=CC5=C (C=C4) N=CC=C5
Molecular Formula
C30H28FN7O3
Additionnal Information
Rebastinib (DCC-2036) is a conformational control Bcr-Abl inhibitor for Abl1 (WT) and Abl1 (T315I) with IC50 of 0.8 nM and 4 nM, also inhibits SRC, LYN, FGR, HCK, KDR, FLT3, and Tie-2, and low activity to seen towards c-Kit. Phase 1.
Storage Conditions
2 years -80 in solvent
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
213778 100 µL
THRB (Thyroid Hormone Receptor beta, Nuclear Receptor Subfamily 1 Group A Member 2, GRTH, PRTH, THR1, ERBA2, NR1A2, THRB1, THRB2, C-ERBA-2, C-ERBA-BETA)
Ask
View Details 